Navigation Links
Dacogen comes to the rescue of MDS

Myelodysplastic syndromes (MDS) is a type of disorder in which in which the bone marrow stops producing mature Red blood cells (RBC). Due to this the patients lack enough// number of RBCs and resulting in improper functioning of the body. Typical symptoms include weakness, fatigue, infections, easy bruising, bleeding, and fever. Hence the Food and Drug Administration approved Dacogen injections for the treatment of MDS.

These injections promote the normal development of blood cells. The FDA has given the drug an orphan drug status. This is because it is used in the treatment of rare diseases or conditions that affect fewer than 200,000 people in the U.S. the approval has been an alternative for people suffering from MDS as they can avoid blood transfusions says Steven Galson, MD, Director of FDA's Center for Drug Evaluation and Research. As of now there is no clear evidence for the cause of MDS. They can develop following treatment with drugs or radiation therapy for other diseases and can progress to acute myeloid leukemia (AML). Statistics show that about 7,000 to 12,000 new cases are diagnosed yearly in the US.
'"/>




Page: 1

Related medicine news :

1. Now AIDS treatment comes dirt-cheap
2. Shorter infants have lower incomes in later life
3. Joint replacement surgery outcomes may be affected by obesity and diabetes
4. When it comes to health, all chocolates not the same.
5. Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement
6. Gene Therapy Overcomes Heart Failure In Muscular Dystrophy
7. Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment
8. India becomes a member of IARC
9. PET Scans Could Predict Treatment Outcomes In Cancer
10. Nutrigenomics here comes a team to better your future!
11. Inhuman Error: Medicine Becomes Poison, Causing Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... ... September 21, 2017 , ... Innovatum ... at the Global GS1 Healthcare Conference 2017 in Chicago, IL on October 17-19, ... ensuring label quality and improving patient safety. , Microscan , a ...
(Date:9/21/2017)... ... September 21, 2017 , ... A new addiction treatment service ... time when Virginia faces an opioid epidemic. , Last year, Virginia ... 38 percent from 2015, underscoring the need for additional addiction treatment options. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... In ... and Clark College Emeritus Professor of Education Gregory A. Smith examines student privacy ... Asleep at the Switch: Schoolhouse Commercialism, Privacy, and the Failure of Policymaking . ...
(Date:9/20/2017)... ... September 20, 2017 , ... On Thursday, ... Places to Work in the Research Triangle for 2017. , Winners were chosen ... had to meet a threshold in employee participation--a percentage that varies based upon ...
(Date:9/20/2017)... TX (PRWEB) , ... September 20, 2017 , ... ... date of the much-anticipated fall event , Look Awesome This Autumn with ... personalized consultations, special pricing and refreshments. , Mirror Mirror Beauty Boutique is ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... SAN FRANCISCO , Sept. 12, 2017 /PRNewswire/ ... Lifecycle Management Solutions (VLMS), is pleased to announce ... as a member of its Board of Directors ... 2017. ValGenesis VLMS enables life science companies to ... eliminate the use of paper in this process. ...
(Date:9/7/2017)... 7, 2017  For nearly two decades, New Life Agency has been ... Insurance industry. Today, New Life Agency announces a powerful three-way partnership designed ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/6/2017)... -- Robert G. Szewc, M.D., is recognized by Continental Who,s ... his contributions to the Medical field.      ... practice of Kidney and Hypertension Specialists, which specializes in ... He has worked in this position since 2002, and ... as expertise in kidneys, hypertension, chronic disease and anemia, ...
Breaking Medicine Technology: